Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100048441Phase 4Recruiting
Phase 4, randomised trial of Zishen Yutai Pill in Diminished Ovarian Reserve (DOR) and female infertility (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoint: Clinical pregnancy outcome. Started Aug 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100048441.